secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRIDEX CORP (IRIX)
CIK:        0001006045
Form:       8-K
Filed at:   2022-05-12T23:59:59+00:00
Accession:  0001564590-22-019869
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iridex Q1 revenue $13.4M (record), up 12% YoY; net loss $2.4M; guides FY22 rev $57-59M
--------------------------------------------------------------------------------

- Record Q1 revenue $13.4M (+12% YoY); net loss $2.4M ($0.15/sh) vs $2.0M ($0.14/sh) prior year.
- Cyclo G6 product revenue $3.5M (+6%); 14,700 probes sold (+8%). Retina revenue $7.3M (+10%).
- Gross margin improved to 44.6% from 41.3%. Cash $20.6M; net cash used $3.2M in Q1.
- FY2022 guidance: revenue $57-59M; Cyclo G6 probe sales 67k-70k (15-20% growth).
- CEO cites continued adoption of MicroPulse TLT and steps to mitigate supply chain risks.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006045/000156459022019869/0001564590-22-019869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006045/000156459022019869/irix-8k_20220512.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-019869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer